BOPA Introduction to Oncology Course Research Published

The BOPA Introduction to Oncology Course Improves Knowledge of Oncology Pharmacy Professionals.

 

A peer-reviewed article has been published on the Journal of Oncology Pharmacy Practice (JOPP) showing that there are overall knowledge gain for Oncology Pharmacy Professionals after attending BOPA’s Introduction to Oncology course.

This study has demonstrated that overall the ITO course improved the baseline knowledge of the delegates attending the course in November 2023 (+1.21). The delegates were also more confident in verifying SACT prescriptions after the course.

Cracknell N, Parbutt C, Wong C, Ganijee T. A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course. Journal of Oncology Pharmacy Practice. 2024;0(0). doi:10.1177/10781552241259367 (Complementary assess of this article is available to ISOPP members, join no-fee ISOPP now.)

Well done and congratulations to BOPA members and ITO Chairs, Netty Cracknell fBOPA, Catherine Parbutt mBOPA, Clayton Wong mBOPA and Tasneem Ganijee mBOPA on the publication.


#BOPAITO returns to London on 4th and 5th November 2024. Registration information will be announced soon, interested delegates are advised to seek study leave approval from their employers prior to registration.

Latest News

By UK SACT Board Representatives - Joseph Williams and Netty Cracknell on 16th September 2025

Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments

The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…

Read article
By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article